Crossmark

The Value of Anti-angiogenics in Primary Brain Tumor Therapy

Crossref DOI link: https://doi.org/10.1007/978-3-319-31215-6_29-2

Published Online: 2018-02-28

Published Print: 2018

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schorb, E.

Waller, C. F.
License Information

License valid from 2018-01-01
More Information

Chapter History

Received: 29 June 2017, 00:00:00

Accepted: 25 September 2017, 00:00:00

First Online: 28 February 2018